abstract |
The present invention provides a novel CCR2 (CC chemokine receptor 2) of the formula (I) (wherein HET is a group selected from the formulas (IIa), (IIb), (IIc) and (IId)) It relates to antagonists and their use to provide drugs for treating symptoms and diseases, in particular lung and pain diseases such as asthma and COPD. [Chemical 1] (I) [Chemical 2] |